Literature DB >> 20027114

Hereditary breast and ovarian cancer: referral source for genetic assessment and communication regarding assessment with nongenetic clinicians in the community setting.

Debra Morgan1, Heather Sylvester, Frances Lee Lucas, Susan Miesfeldt.   

Abstract

PURPOSE: To examine referral source to cancer genetic services; communication of results of genetic evaluation to clinicians; role of clinicians in postcounseling management; and use of alternative information sources after cancer genetic risk assessment/counseling in the community setting.
METHODS: Retrospective telephone survey.
SETTING: A community/private hospital-based cancer genetic counseling service. PATIENTS: Women, at least 21 years of age, who had undergone cancer genetic counseling with (1) at least a 10% predicted likelihood of carrying a BRCA1/2 mutation or (2) a documented BRCA1/2 mutation. INTERVENTION: A 121-item telephone survey. MAIN OUTCOME MEASURE: (1) initial referral source to cancer genetic services; (2) women's communication of results of cancer genetic assessment to primary and (nongenetic) specialist clinician(s); (3) education and support role played by subjects' physician(s); and (4) use of other hereditary breast and ovarian cancer (HBOC) information resources.
RESULTS: Of 225 women eligible for study, 69 (31%) completed the survey. Sixty-two percent were referred by their medical oncologist; 13% by their primary care physician, and fewer by their surgeon (6%) or gynecologist (4%). Results of the cancer genetic assessment were not shared with 19% of primary care clinicians, 26% of primary gynecologists, 12% of oncologists, and 36% of surgeons. Twenty-six percent of participants noted that their primary care clinician had not been involved in their HBOC-related, cancer prevention decisions, 16% had not included their gynecologist, 2% had not involved their oncologist, and 20% replied that their surgeon had not been involved in these decisions. Overall, clinicians were perceived as supportive when it came to a participants' information and decision support needs. One exception was that 21% of respondents reported the use by clinicians of medical terms, without definition. Over two-thirds had sought alternative "self-help" HBOC-related materials, most Internet based.
CONCLUSIONS: These results have implications for interdisciplinary communication and decision support for those with or at risk for HBOC, cared for in the community setting.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20027114     DOI: 10.1097/GIM.0b013e3181c60955

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  6 in total

1.  Who is being referred to cancer genetic counseling? Characteristics of counselees and their referral.

Authors:  E van Riel; S van Dulmen; M G E M Ausems
Journal:  J Community Genet       Date:  2012-03-17

2.  Communication of BRCA1 and BRCA2 genetic test results to health care providers following genetic testing at a tertiary care center.

Authors:  K Ready; B K Arun; K M Schmeler; A Uyei; J K Litton; K H Lu; C C Sun; S K Peterson
Journal:  Fam Cancer       Date:  2011-12       Impact factor: 2.375

3.  Breadth of Genetic Testing Selected by Patients at Risk of Hereditary Breast and Ovarian Cancer.

Authors:  J Brian Szender; Jasmine Kaur; Katherine Clayback; Mollie L Hutton; June Mikkelson; Kunle Odunsi; Cara Dresbold
Journal:  Int J Gynecol Cancer       Date:  2018-01       Impact factor: 3.437

4.  Development of an integrated support system for hereditary cancer and its impact on gynecologic services.

Authors:  Mina Morii-Kashima; Hiroshi Tsubamoto; Chika Sato; Mariko Ushioda; Naohiro Tomita; Yasuo Miyoshi; Tomoko Hashimoto-Tamaoki; Kazuo Tamura; Hideaki Sawai; Hiroaki Shibahara
Journal:  Int J Clin Oncol       Date:  2013-12-19       Impact factor: 3.402

5.  Familial breast cancer: Genetic counseling over time, including patients´ expectations and initiators considering the Angelina Jolie effect.

Authors:  Christina Evers; Christine Fischer; Nicola Dikow; Sarah Schott
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

6.  Do Breast Cancer Patients Tested in the Oncology Care Setting Share BRCA Mutation Results with Family Members and Health Care Providers?

Authors:  Susan T Vadaparampil; Teri Malo; Cara de la Cruz; Juliette Christie
Journal:  J Cancer Epidemiol       Date:  2012-07-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.